/cloudfront-us-east-1.images.arcpublishing.com/mco/KQLK3YNIUZH4HMZYW2JG3JZE34.jpg)
VA says it’ll stop almost all use of unproven drug on vets for coronavirus
Veterans Affairs Secretary Robert Wilkie said Thursday that his department has all but stopped use of an unproven malaria drug on veterans with COVID-19.
-
-
VA patient deaths from coronavirus hit 1,200, but leaders see progress
VA Secretary Robert Wilkie described the department response so far to the virus as a great success.
-
Trump extends Guard coronavirus missions until mid-August
The move extends the deployments from 89 days to more than 120.
-
Amid criticism, Secretary Wilkie won’t commit to removing Nazi headstones from VA cemeteries
Swastikas on at least three headstones at two cemeteries have stirred controversy in recent weeks.
-
Cost-of-living boost for veterans benefits next year passes House
The legislation would tie the 2021 Social Security COLA to veterans benefits increases.
-
Veterans Affairs budget hearing represents first steps toward normal operations for Congress
Secretary Robert Wilkie is scheduled to testify on Thursday morning about VA's annual budget request.
-
Memorial Day even more poignant as veterans die from virus
This year's Memorial Day will pay tribute not only to those who died on the battlefield but more recent fallen soldiers.
-
What does success after service look like for our veterans?
Now is the time for our country to explore new approaches to caring for our veterans and aiding their transition back into civilian life, says the chairman of the Senate Veterans Affairs Committee in this commentary.
-
As coronavirus deaths rise, but cases drop, VA defends continued use of controversial drug
More than 1,100 VA patients have died from the virus since early March.
-
Suicide risk for veterans could grow as coronavirus crisis winds down
Mental health experts warn that feelings of depression and anxiety will likely outlast the immediate isolation of the pandemic.
/cloudfront-us-east-1.images.arcpublishing.com/mco/VHKYQS6P7NBKLEMTBVTQNJJ34Q.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/mco/XWA5XEM3EVH6FIOIYMBJPOS2WI.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/mco/L7U5CZPKBZHVHAE7MUMIPEIUW4.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/mco/VMJ7PLDTDBGETERWPITQV4XYLY.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/mco/JR7PWJQCBBABLL3TS77VLOPBXE.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/mco/6ILL3JRZXJHHTMEVIX4BNUZ7VE.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/mco/SZTVSQ3TIBEFDA7Z3YOGTTFLSI.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/mco/Q5ZNTNFZ4FBGZCLK5444Z5PVSA.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/mco/BYGPWECHVZGURHVMCGZ2VYIWCQ.jpg)